2000 MG Liposomal Nicotinamide Riboside Supplement - High Absorption

In this review of Aesticum's 2000 MG Liposomal Nicotinamide Riboside Supplement, the bottom line is simple: this formula is aimed at adults looking to support cellular energy and age defense by boosting NAD+. The reviewer found the product notable for its very high total content and the use of liposome delivery, which addresses common absorption concerns with high-dose supplements. For people already familiar with NR supplements who want a concentrated daily regimen, the blend of nicotinamide riboside, TMG and trans-pterostilbene makes this an attractive option worth testing.

Key Features

• High content: A single serving strategy delivers a total 2000 mg blend with 1500 mg nicotinamide riboside to provide a strong precursor dose for NAD+ support.
• Liposomal delivery: Encapsulating ingredients in liposomes helps protect active compounds through the digestive tract for potentially better blood absorption compared with standard capsules.
• TMG included: The 300 mg of betaine anhydrous (TMG) supports methylation pathways and complements NAD+ metabolism and DNA repair processes.
• Pterostilbene antioxidant: The 200 mg trans-pterostilbene addition adds an antioxidant that may support sirtuin activation and cellular wellness.
• Dietary assurances: The product is tested, non-GMO, gluten-free, no-dairy and made in USA, which is important for consumers seeking clean supplement sourcing.

Who It's For

This supplement is best for adults seeking higher-dose nicotinamide riboside to intentionally raise NAD+ precursors, especially those who are already comfortable with concentrated NAD+ boosting protocols and want a single product that combines NR with TMG and pterostilbene. It also suits shoppers who prioritize formulations made in the USA and clear dietary labels like non-GMO and gluten-free.

Those who should look elsewhere include first-time users who prefer low-dose starter products or clinicians recommending modest NR dosages; also people who need products free of softgel carriers or who prefer a powdered dose may find tablets or powders a better fit.

Pros & Cons

Pros

• Very high nicotinamide riboside content per suggested daily regimen for pronounced NAD+ precursor support.
• Liposome technology targets improved absorption and bioavailability compared with regular capsules.
• Complementary ingredients TMG and trans-pterostilbene address methylation and antioxidant support in the same formula.
• Manufactured under tested, non-GMO, gluten-free, no-dairy standards in the USA.

Cons

• High total milligram dosing may be more than some users want to start with, so gradual introduction might be prudent.
• Softgel format and concentrated dose may not suit those preferring chewable or powder forms.

Specifications

Brand	Aesticum
Total content	2000 mg per serving blend
Nicotinamide Riboside	1500 mg (total in product; two softgels recommended)
Trans-Pterostilbene	200 mg
Betaine Anhydrous (TMG)	300 mg
Format	120 softgels, liposomal technology
Dietary info	Tested, non-GMO, gluten-free, no-dairy, made in USA

Our Verdict

For shoppers focused on raising NAD+ precursors with a concentrated, research-minded formula, this liposomal nicotinamide riboside product is a strong choice because it combines a high NR dose with TMG and pterostilbene and uses liposome delivery to address absorption. It represents solid value for experienced users seeking a full daily protocol, though newcomers may prefer to begin at lower doses.

Frequently Asked Questions

How much should I take?
Answer. The product recommends two softgels daily to reach the higher nicotinamide riboside dose; users can consult a healthcare professional about starting amounts.

Does liposomal delivery improve results?
Answer. Liposomes protect actives through digestion and can enhance bioavailability, which is why this formula uses liposomal technology for better absorption.

Is it suitable for restricted diets?
Answer. Yes, the formula is labeled non-GMO, gluten-free and no-dairy, and it is manufactured in the USA.